{"id":30225,"date":"2025-03-24T22:12:38","date_gmt":"2025-03-24T14:12:38","guid":{"rendered":"https:\/\/flcube.com\/?p=30225"},"modified":"2025-03-24T22:12:39","modified_gmt":"2025-03-24T14:12:39","slug":"eli-lilly-launches-lilly-gateway-laboratory-in-china-to-boost-biotech-innovation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30225","title":{"rendered":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation"},"content":{"rendered":"\n

US major Eli Lilly & Co., (NYSE: LLY<\/a>) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.<\/p>\n\n\n\n

Facility Highlights<\/strong>
The LGL offers a comprehensive environment for biotech startups to thrive. The facility features advanced laboratory equipment, flexible meeting spaces, and modern office amenities, all aimed at creating an optimal environment for research and collaboration. By providing these resources, Eli Lilly aims to foster a vibrant ecosystem for scientific advancement and accelerate the development of novel therapies.<\/p>\n\n\n\n

First Resident: 4B Technologies Investments Ltd<\/strong>
China-based 4B Technologies Investments Ltd, a biotech company focused on central nervous system (CNS) drug development, is the first resident of the Beijing incubator. The company has four novel drugs at clinical stages and has established research and development platforms for animal models of neurological diseases and cerebral organoids. This residency marks a significant step for 4B Technologies in advancing its CNS drug pipeline and leveraging the LGL’s resources to accelerate its development efforts.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly…<\/p>\n","protected":false},"author":1,"featured_media":30226,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[30,199,911],"class_list":["post-30225","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-biotech","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"\nEli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30225\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation\" \/>\n<meta property=\"og:description\" content=\"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30225\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T14:12:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-24T14:12:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"475\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation\",\"datePublished\":\"2025-03-24T14:12:38+00:00\",\"dateModified\":\"2025-03-24T14:12:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225\"},\"wordCount\":225,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2406-1-png.webp\",\"keywords\":[\"Biotech\",\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30225#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30225\",\"name\":\"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2406-1-png.webp\",\"datePublished\":\"2025-03-24T14:12:38+00:00\",\"dateModified\":\"2025-03-24T14:12:39+00:00\",\"description\":\"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30225\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2406-1-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2406-1-png.webp\",\"width\":1080,\"height\":475,\"caption\":\"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30225#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation - Insight, China's Pharmaceutical Industry","description":"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30225","og_locale":"en_US","og_type":"article","og_title":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation","og_description":"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.","og_url":"https:\/\/flcube.com\/?p=30225","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-24T14:12:38+00:00","article_modified_time":"2025-03-24T14:12:39+00:00","og_image":[{"width":1080,"height":475,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30225#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30225"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation","datePublished":"2025-03-24T14:12:38+00:00","dateModified":"2025-03-24T14:12:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30225"},"wordCount":225,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=30225#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","keywords":["Biotech","Eli Lilly","NYSE: LLY"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30225#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30225","url":"https:\/\/flcube.com\/?p=30225","name":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=30225#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=30225#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","datePublished":"2025-03-24T14:12:38+00:00","dateModified":"2025-03-24T14:12:39+00:00","description":"US major Eli Lilly & Co., (NYSE: LLY) has announced the opening of the Lilly Gateway Laboratory (LGL) in China. This state-of-the-art facility, the fourth of its kind globally, is equipped with first-class ready-to-use laboratories, shared meeting rooms, and convenient workstations. The laboratory is designed to support the growth of early-stage biotechnology companies, promote scientific innovation, enhance drug development efficiency, and reduce the time to market for new drugs.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30225#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30225"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=30225#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","width":1080,"height":475,"caption":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30225#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2406-1-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30225"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30225\/revisions"}],"predecessor-version":[{"id":30227,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30225\/revisions\/30227"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/30226"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}